Journal Information
Vol. 31. Issue 3.
Pages 263-264 (March 2012)
Share
Share
Download PDF
More article options
Vol. 31. Issue 3.
Pages 263-264 (March 2012)
Recommended article of the month
Open Access
Comment on “Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial”
Visits
4681
Daniel Ferreira
Member of the Editorial Board of the Revista Portuguesa de Cardiologia
This item has received

Under a Creative Commons license
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract
Background

Although practice guidelines recommend out-patient care for selected, haemodynamically stable patients with pulmonary embolism, most treatment is presently inpa-tient based. We aimed to assess non-inferiority of outpatient care compared with inpatient care.

Methods

We undertook an open-label, randomised non-inferiority trial at 19 emergency departments in Switzerland, France, Belgium, and the USA. We ran-domly assigned patients with acute, symptomatic pulmonary embolism and a low risk of death (pulmonary embolism severity index risk classes I or II) with a computer-generated randomisation sequence (blocks of 2-4) in a 1:1 ratio to initial outpatient (ie, discharged from hospital ≤24h after randomisation) or inpatient treatment with subcuta-neous enoxaparin (≥5 days) followed by oral anticoagulation (≥90 days). The primary outcome was symptomatic, recur-rent venous thromboembolism within 90 days; safety outcomes included major bleeding within 14 or 90 days and mortality within 90 days. We used a non-inferiority margin of 4% for a difference between inpatient and outpatient groups. We included all enrolled patients in the primary analysis, excluding those lost to follow-up. This trial is reg-istered with ClinicalTrials.gov, number NCT00425542.

Findings

Between February, 2007, and June, 2010, we enrolled 344 eligible patients. In the primary analysis, one (0.6%) of 171 outpatients developed recurrent venous thromboembolism within 90 days compared with none of 168 inpatients (95% upper confidence limit [UCL] 2.7%; p=0.011). Only one (0.6%) patient in each treatment group died within 90 days (95% UCL 2.1%; p=0.005), and two (1.2%) of 171 outpatients and no inpatients had major bleeding within 14 days (95% UCL 3.6%; p=0.031). By 90 days, three (1.8%) outpatients but no inpatients had developed major bleeding (95% UCL 4.5%; p=0.086). Mean length of stay was 0.5 days (SD 1.0) for outpatients and 3.9 days (SD 3.1) for inpatients.

Interpretation

In selected low-risk patients with pul-monary embolism, outpatient care can safely and effectively be used in place of inpatient care.

Full text is only aviable in PDF
References
[1]
A. Torbicki, A. Perrier, S. Konstantinides, et al.
Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).
European Heart Journal, 29 (2008), pp. 2276-2315
[2]
J. Donzé, G. Le Gal, M.J. Fine, P.-M. Roy, O. Sanchez, F. Verschuren, et al.
Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism.
Thrombosis and haemostasis, 100 (2008), pp. 943-948
[3]
L. Moores, D. Aujesky, D. Jiménez, et al.
Pulmonary Embolism Severity Index and troponin testing for the selection of low-risk patients with acute symptomatic pulmonary embolism.
Journal of Thrombosis and Haemostasis, 8 (2010), pp. 517-522
[4]
A. Squizzato, M. Galli, F. Dentali, et al.
Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review.
The European Respiratory Journal, 33 (2009), pp. 1148-1155
[5]
M. Janjua, A. Badshah, F. Matta, et al.
Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review.
Thrombosis and haemostasis, 100 (2008), pp. 756-761
[6]
D. Aujesky, P.-M. Roy, F. Verschuren, et al.
Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial.
Copyright © 2012. Sociedade Portuguesa de Cardiologia
Download PDF
Idiomas
Revista Portuguesa de Cardiologia (English edition)
Article options
Tools
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.